Neuroscience Research Australia, Cnr Barker St and Easy St, Randwick, Sydney, NSW 2031, Australia.
Brain. 2011 Sep;134(Pt 9):2582-94. doi: 10.1093/brain/awr195. Epub 2011 Aug 11.
Frontotemporal dementia and motor neuron disease share clinical, genetic and pathological characteristics. Motor neuron disease develops in a proportion of patients with frontotemporal dementia, but the incidence, severity and functional significance of motor system dysfunction in patients with frontotemporal dementia has not been determined. Neurophysiological biomarkers have been developed to document motor system dysfunction including: short-interval intracortical inhibition, a marker of corticospinal motor neuron dysfunction and the neurophysiological index, a marker of lower motor neuron dysfunction. The present study performed detailed clinical and neurophysiological assessments on 108 participants including 40 consecutive patients with frontotemporal dementia, 42 age- and gender-matched patients with motor neuron disease and 26 control subjects. Of the 40 patients with frontotemporal dementia, 12.5% had concomitant motor neuron disease. A further 27.3% of the patients with frontotemporal dementia had clinical evidence of minor motor system dysfunction such as occasional fasciculations, mild wasting or weakness. Biomarkers of motor system function were abnormal in frontotemporal dementia. Average short-interval intracortical inhibition was reduced in frontotemporal dementia (4.3 ± 1.7%) compared with controls (9.1 ± 1.1%, P < 0.05). Short-interval intracortical inhibition was particularly reduced in the progressive non-fluent aphasia subgroup, but was normal in patients with behavioural variant frontotemporal dementia and semantic dementia. The neurophysiological index was reduced in frontotemporal dementia (1.1) compared with controls (1.9, P < 0.001), indicating a degree of lower motor neuron dysfunction, although remained relatively preserved when compared with motor neuron disease (0.7, P < 0.05). Motor system dysfunction in frontotemporal dementia may result from pathological involvement of the primary motor cortex, with secondary degeneration of lower motor neurons in the brainstem and anterior horn of the spinal cord.
额颞叶痴呆和运动神经元病具有相似的临床、遗传和病理学特征。在一部分额颞叶痴呆患者中会发展为运动神经元病,但额颞叶痴呆患者的运动系统功能障碍的发病率、严重程度和功能意义尚未确定。神经生理生物标志物已被开发出来,用于记录运动系统功能障碍,包括:短间隔皮质内抑制,这是皮质脊髓运动神经元功能障碍的标志物,以及神经生理指数,这是下运动神经元功能障碍的标志物。本研究对 108 名参与者进行了详细的临床和神经生理评估,其中包括 40 名连续的额颞叶痴呆患者、42 名年龄和性别匹配的运动神经元病患者和 26 名对照受试者。在 40 名额颞叶痴呆患者中,有 12.5%的患者同时患有运动神经元病。另有 27.3%的额颞叶痴呆患者存在轻微运动系统功能障碍的临床证据,如偶尔出现肌束震颤、轻度废用或无力。运动系统功能的生物标志物在额颞叶痴呆中异常。与对照组相比(9.1±1.1%,P<0.05),额颞叶痴呆患者的平均短间隔皮质内抑制降低(4.3±1.7%)。皮质内抑制在进行性非流利性失语亚组中尤其降低,但在行为变异型额颞叶痴呆和语义性痴呆患者中正常。与对照组相比(1.9,P<0.001),额颞叶痴呆患者的神经生理指数降低(1.1),表明存在一定程度的下运动神经元功能障碍,但与运动神经元病相比相对保留(0.7,P<0.05)。额颞叶痴呆患者的运动系统功能障碍可能是由于初级运动皮层的病理累及所致,随后脑干和脊髓前角的下运动神经元发生继发性变性。